Benjamin F. Edwards & Company Inc. Sells 375 Shares of Davis Select U.S. Equity ETF (NASDAQ:DUSA)

Benjamin F. Edwards & Company Inc. lowered its holdings in Davis Select U.S. Equity ETF (NASDAQ:DUSAGet Rating) by 29.0% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 920 shares of the healthcare company’s stock after selling 375 shares during the period. Benjamin F. Edwards & Company Inc.’s holdings in Davis Select U.S. Equity ETF were worth $30,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of the business. Steward Partners Investment Advisory LLC lifted its holdings in shares of Davis Select U.S. Equity ETF by 9.5% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 6,325 shares of the healthcare company’s stock worth $216,000 after acquiring an additional 550 shares during the period. Good Life Advisors LLC bought a new stake in shares of Davis Select U.S. Equity ETF during the 4th quarter worth approximately $223,000. WFA of San Diego LLC lifted its holdings in shares of Davis Select U.S. Equity ETF by 30.0% during the 4th quarter. WFA of San Diego LLC now owns 9,985 shares of the healthcare company’s stock worth $341,000 after acquiring an additional 2,307 shares during the period. Melone Private Wealth LLC bought a new stake in shares of Davis Select U.S. Equity ETF during the 1st quarter worth approximately $353,000. Finally, Kathleen S. Wright Associates Inc. bought a new stake in shares of Davis Select U.S. Equity ETF during the 4th quarter worth approximately $765,000.

Davis Select U.S. Equity ETF Stock Down 0.8 %

Shares of Davis Select U.S. Equity ETF stock opened at $28.55 on Wednesday. The company has a 50 day moving average of $28.42 and a 200-day moving average of $30.97. Davis Select U.S. Equity ETF has a 1-year low of $26.64 and a 1-year high of $36.42.

About Davis Select U.S. Equity ETF

(Get Rating)

DUSA Pharmaceuticals, Inc (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company’s marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp.

Featured Stories

Want to see what other hedge funds are holding DUSA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davis Select U.S. Equity ETF (NASDAQ:DUSAGet Rating).

Institutional Ownership by Quarter for Davis Select U.S. Equity ETF (NASDAQ:DUSA)

Want More Great Investing Ideas?

Receive News & Ratings for Davis Select U.S. Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davis Select U.S. Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.